Radiation Therapy & Targeted Tumors

Angiogenesis Inhibitors

Angiogenesis inhibitors are drugs that block angiogenesis. These drugs are also called anti-angiogenics. Blocking nutrients and oxygen from a tumor can “starve” it. Angiogenesis inhibitors are unique cancer-fighting agents because they block the growth of blood vessels that support tumor growth rather than blocking the growth of tumor cells themselves. The U.S. Food and Drug Administration (FDA) has approved a number of angiogenesis inhibitors to treat cancer. Approved angiogenesis inhibitors include:

• Axitinib
• Bevacizumab
• Cabozantinib
• Everolimus
• Lenalidomide
• Lenvatinib mesylate
• Pazopanib
• Ramucirumab